輸入代號或公司名稱後按 Enter
4128

中天

+0.05 (+0.34%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
14.55359成交張數16.29本益比0.90股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20251,894年增 +9.9%
毛利率202539.8%最新一期
營業利益率2025-21.5%最新一期
每股盈餘2025-1.29
會計項目走勢2016201720182019202020212022202320242025
銷貨收入淨額96.9%98.1%98.3%98.3%98.2%97.9%98.2%97.6%97.0%96.7%
其他營業收入淨額3.1%1.9%1.7%1.7%1.8%2.1%1.8%2.4%3.0%3.3%
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計61.8%63.1%60.6%60.4%60.4%58.5%59.9%62.1%60.8%60.2%
營業毛利(毛損)38.2%36.9%39.4%39.6%39.6%41.5%40.1%37.9%39.2%39.8%
營業毛利(毛損)淨額38.2%36.9%39.4%39.6%39.6%41.5%40.1%37.9%39.2%39.8%
推銷費用33.0%34.7%32.6%31.5%34.9%31.8%31.2%32.7%31.9%31.6%
管理費用10.9%13.3%13.1%12.3%51.7%26.6%9.8%11.7%11.0%10.3%
研究發展費用11.9%6.2%2.8%6.7%22.0%48.3%15.4%25.4%22.6%19.4%
營業費用合計55.8%54.3%48.5%50.6%108.6%106.8%56.4%69.8%65.4%61.3%
其他收益及費損淨額-0.0%0.1%0.1%0.0%0.1%0.0%0.0%
營業利益(損失)-17.7%-17.4%-9.1%-11.0%-69.0%-65.2%-16.2%-31.8%-26.2%-21.5%
利息收入3.5%2.0%2.5%5.6%4.8%3.3%
其他收入3.6%2.9%2.8%5.6%2.0%0.5%0.4%0.4%0.6%0.8%
其他利益及損失淨額-7.9%53.8%-4.3%3.6%-6.7%9.6%8.7%5.8%1.4%-2.1%
財務成本淨額0.5%0.5%0.2%0.6%0.5%0.3%0.4%0.5%0.6%0.6%
採用權益法認列之關聯企業及合資損益之份額淨額0.7%-4.0%-39.4%-15.0%103.1%40.4%13.7%-66.1%-54.2%-30.2%
營業外收入及支出合計-4.1%52.2%-41.1%-6.4%101.4%52.2%25.0%-54.8%-48.0%-28.8%
稅前淨利(淨損)-21.8%34.8%-50.2%-17.4%32.4%-13.0%8.8%-86.6%-74.2%-50.2%
所得稅費用(利益)合計0.7%0.7%0.7%0.7%-0.0%0.1%-0.0%-0.0%0.0%0.1%
繼續營業單位本期淨利(淨損)-22.5%34.1%-50.9%-18.0%32.5%-13.1%8.9%-86.5%-74.2%-50.3%
本期淨利(淨損)-22.5%34.1%-50.9%-18.0%32.5%-13.1%8.9%-86.5%-74.2%-50.3%
確定福利計畫之再衡量數-0.3%-0.3%-0.3%-0.0%-0.0%-0.0%0.4%0.1%0.3%0.1%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-2.1%0.3%8.6%1.2%-2.0%1.8%-2.1%-4.9%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目-11.0%1.5%62.5%13.4%-5.3%-3.4%-24.9%-29.1%
與不重分類之項目相關之所得稅-0.0%-0.0%0.0%0.0%0.0%-0.0%0.0%-0.0%0.0%0.0%
不重分類至損益之項目:1.8%71.1%14.5%-7.0%-1.5%-26.7%-33.9%
國外營運機構財務報表換算之兌換差額-4.5%-1.6%-2.8%-8.0%3.3%0.3%2.1%-1.8%4.1%-4.3%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-1.3%0.6%-0.2%0.6%-0.6%1.5%-0.7%
後續可能重分類至損益之項目:-9.3%3.9%0.1%2.7%-2.5%5.5%-4.9%
其他綜合損益(淨額)-13.0%-6.7%-15.3%-7.5%75.0%14.6%-4.3%-4.0%-21.2%-38.8%
本期綜合損益總額-35.4%27.4%-66.2%-25.5%107.4%1.6%4.6%-90.6%-95.4%-89.2%
母公司業主(淨利∕損)-17.6%38.4%-47.7%-15.9%41.5%2.8%12.3%-74.1%-63.9%-40.0%
非控制權益(淨利∕損)-4.9%-4.3%-3.2%-2.1%-9.0%-15.9%-3.4%-12.4%-10.3%-10.3%
母公司業主(綜合損益)-27.3%32.6%-60.9%-17.3%113.8%16.8%6.5%-76.4%-88.0%-74.6%
非控制權益(綜合損益)-8.2%-5.2%-5.3%-8.2%-6.4%-15.2%-1.9%-14.2%-7.3%-14.6%
基本每股盈餘-0.0%0.1%-0.1%-0.0%0.1%0.0%0.0%-0.1%-0.1%-0.1%
稀釋每股盈餘-0.0%0.1%-0.1%-0.0%0.1%0.0%0.0%-0.1%-0.1%-0.1%
預期信用減損損失(利益)0.0%0.0%0.0%
備供出售金融資產未實現評價損益7.4%0.0%0.0%
採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-16.0%-5.1%0.9%
與可能重分類之項目相關之所得稅-0.6%-0.2%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。